Neuroscience Institute Headache Center Intake Form. Please list ALL medications you are currently taking, including over-the-counter

Size: px
Start display at page:

Download "Neuroscience Institute Headache Center Intake Form. Please list ALL medications you are currently taking, including over-the-counter"

Transcription

1 Neuroscience Institute Headache Center Intake Form Please list ALL medications you are currently taking, including over-the-counter medications and supplements: Medication Allergies: Past Medical History:

2 Past Surgical History: Family History: Do you currently or have you ever smoked? If yes, how many pack per day? If yes, how long have you been smoking? If former smoker, how long ago did you quit? Do you consume alcohol? If yes, how many alcoholic beverages do you consume per day/per week? Do you use any drugs? If yes, which?

3 If yes, how many times per week? Age of first headache: When was your last headache? How many times a week do you experience any kind of headache? How many times per month do experience headaches? Are you ever headache free? Have you ever required emergency room management of your headache? If yes, when was your last emergency room visit? Are there any triggers to your headache? Any warning signs prior to headache onset? Any family history of headaches of any kind? In the last 3 months, how many days of work were missed due to headache? How many caffeinated beverages do you consume daily? Do you snore? On a scale of 1-10, how stressful is your current life situation? Is there any history of physical, emotional, verbal, or sexual abuse currently or in the past?

4 MIDAS (MIGRAINE DISABILITY ASSESSMENT) 1. On how many days in the last 3 months did you miss work or school because of your headaches? (If you do not attend work or school enter ZERO) 2. How many days in the last 3 months was your productivity at work or school reduced by half or more because of your headaches? (Do not include days you counted in question 1 where you missed work or school. If you do not attend school or work enter ZERO) 3. On how many days in the last 3 months did you not do household work because of your headaches? 4. How many days in the last 3 months was your productivity in household work reduced by half or more because of your headaches? (Do not include days you counted in question 1 where you missed work or school. If you do not attend school or work enter ZERO) 5. On how many days in the last 3 months did you miss family, social, or leisure activities because of your headaches? Total Score from questions 1-5: A. On how many days in the last 3 months did you have a headache?

5 (If headache lasted more than 1 day, count each day) B. On a scale of 0-10, on average, how painful were these headaches? (0=no pain at all, and 10=worst pain ever) PH-Q9 Over the last 2 weeks, how often have you been bothered by any of the following problems? Not at all Several Days More than half of the days Nearly Every day 1. Little interest or pleasure in doing things Feeling down, depressed or hopeless Trouble falling or staying asleep, or sleeping too much 4. Feeling tired or having little energy Poor appetite or overeating Feeling bad about yourself-or that you are a failure or have let yourself or your family down 7. Trouble concentrating on things, such as reading the newspaper or watching television 8. Moving or speaking slowly that other people could have noticed? Or the opposite- being so fidgety and restless that you have been moving around more than usual Thoughts that you would better off dead or hurting yourself in some way Total Score: If you checked off any problems, how difficult have these problems made it for you to do your work, take care of things at home, or get along with other people?

6 Not difficult at all Somewhat difficult Very difficult Extremely difficult EPWORTH SLEEPINESS SCALE 0 = no chance of dozing 1 = slight chance of dozing 2 = moderate chance of dozing 3 = high chance of dozing SITUATION CHANCE OF DOZING Sitting and reading Watching TV Sitting inactive in a public place (e.g a theater or a meeting) As a passenger in a car for an hour without a break Lying down to rest in the afternoon when circumstances permit

7 Sitting and talking to someone Sitting quietly after a lunch without alcohol In a car, while stopped for a few minutes in traffic TOTAL SCORE: Please Circle medications that you have previously tried: TRIPTANS Almotriptan (Axert) Frovatriptan (Frova) Naratriptan (Amerge) Rizatriptan (Maxalt) Sumatriptan -oral, inj, nasal (Imitrex)

8 Zolmitriptan -oral, nasal (Zomig) Eletriptan (Relpax) NSAIDS Aspirin Diclofenac (Voltaren, Cambia) Etodolac (Lodine) Ibuprofen (Motrin) Ketorolac (Toradol) Indomethacin (Indocin) Ketoprofem (Orudis) Naproxen sodium (Naprosyn) COX2 Celexcoxib (eg Celebrex) Analgesics and Combination Medications Acetaminpophen/caffeine/butalbital (Fioricet) Aspirin/caffeine/butalbital (Fiorinal) Isometheptene/acetaminophen/ dichloralphenazone (Midrin) Acetaminophen/aspirin/caffeine (Excedrin Migraine) Acetaminophen (Tylenol) Decongestants (Sudafed) NARCOTIC/ OPIOIDS Butorphanol (Stadol) Fentanyl (Duragesic) Codeine Meperidine (Demerol) Long acting oxycodone (Oxycontin)

9 Oxycodone (Percocet) Tramadol (Ultram) Buprenorphine (Butrans) Morphine Hydromorphone (Dilaudid) Hydrocodone (Vicodin) Methadone ERGOTS Bromocriptine (eg Parlodel) Cafergot Dihydroergotamine IV, IM, Inhaled (DHE) Methylergonovine (eg Methergine) Anti-Histamines Diphenhydramine (Benadryl) Cyproheptadine (eg Periactin) Hydroxyzine (Vistaril, Atarax) MUSCLE RELAXANTS Baclofen (Lioresal) Carisoprodol (Soma) Cyclobenzaprine (Flexeril) Methocarbamol (Robaxin) Orphenadrine (Norflex) Tizanidine (Zanaflex) BENZODIAZEPINES/ TRANQUILIZERS Alprazolam (Xanax) Buspirone (Buspar) Clonazepam (Klonopin) Diazepam (Valium) Lorazepam (eg Ativan) Zolpidem (Ambien)

10 STEROIDS Dexamethasone (Decadron, Medrol) Methylprednisolone (Solu-Medrol) Prednisone (Deltasone) Meclizine (Antivert) ANTINAUSEA Metolopramide (Reglan) Prochlorperazine (Compazine) Promethazine (Phenergan) Ondansetron (Zofran) ANTICONVULSANTS Carbamazepine (Tegretol) Gabapentin (Neurontin) Lamotrigine (Lamictal) Levetiracetam (Keppra) Oxcarbazepine (Trileptal) Phenobarbital Phenytoin (Dilantin) Pregabalin (Lyrica) Topiramate (Topamax) Topamax XR (Trokendi) Valproic Acid (Depakote) Zonisamide (Zonegran)

11 Amitriptyline (Elavil) ANTIDEPRESSANTS Bupropion (Wellbutrin) Duloxetine (Cymbalta) Desipramine (Norpramin) Doxepin (Zonalon) Imipramine (Trofanil) Mirtazapine (Remeron) Nortriptyline (Pamelor) Trazodone Venlafaxine (Effexor) BETA BLOCKERS Atenolol (Tenormin) Metoprolol (Lopressor) Nadolol (Corgard) Propranolol (Inderal) CALCIUM CHANNEL BLOCKERS Amlodipine (Norvasc) Diltiazem (Cardizem) Nifedipine (Procardia) Verapamil (Calan) Candesartan (Atacand) Enalapril (Vasotec) ACE INHIBITORS Captopril (Capoten) Lisinopril (Zestril) DIURETIC Acetazolamide (Diamox) Furosemide (Lasix)

12 MAO INHIBITORS Isocarboxazid (Marplan) Phenelzine (Nardil) Tranylcypromine (eg Parnate) ALPHA-ADRENERGIC BLOCKERS Clonidine (Catapres) Doxazosin (Caradura) ANTI-PSYCHOTICS Haloperidol (Haldol) Quetiapine (Seroquel) Risperidone (Risperdal) STIMULANTS/MOOD STABILIZERS Dextroamphetamine (Dexedrine) Lithium (Lithobid) Methylphenidate (Ritalin) HORMONES Estrogen/progesterone (many OCPs) Estrogen (Premarin) Medroxyprogesterone (Provera)

13 Occipital Nerve Blocks INJECTABLES OnabotulinumtoxinA (Botox) Sphenopalatine Ganglion Block Trigeminal Nerve Blocks (supraorbital, supratrochlear, auriculotemporal, infraorbital) SUPPLEMENTS Butterbur (Petadolex) Co Q 10 Feverfew Magnesium Melatonin Migrelief Vitamin B2 NEUROMODULATION Cefaly GammaCore Transcranial Magnetic Stimulation (TMS) NON-MEDICATION TREATMENTS Biofeedback Cognitive Behavioral Therapy Meditation Craniosacral Therapy Acupuncture Physical Therapy

14

-On average, on a scale of 1-10 with 10 being the worst pain you can imagine, what is the range of pain intensity?

-On average, on a scale of 1-10 with 10 being the worst pain you can imagine, what is the range of pain intensity? New Patient Consultation Mia Minen, MD, MPH Patient Name: Sex: Age: Date: Date of Birth: Referring Physician: Which hand do you write with: Right / Left / Ambidextrous Height: Weight: Please briefly describe

More information

COLUMBIA UNIVERSITY HEADACHE CENTER: NEW PATIENT QUESTIONNAIRE

COLUMBIA UNIVERSITY HEADACHE CENTER: NEW PATIENT QUESTIONNAIRE COLUMBIA UNIVERSITY HEADACHE CENTER: NEW PATIENT QUESTIONNAIRE HEADACHE CHARACTERISTICS Frequency and Severity 1. At what AGE did you get your first headache, of ANY kind? 2. At what AGE did your headaches

More information

~ ColumbiaDoctors Adult New Patient Intake Form Patient Information

~ ColumbiaDoctors Adult New Patient Intake Form Patient Information ~ ColumbiaDoctors Adult New Patient Intake Form Patient Information Last Name: First Name: DOB: Gender: Home Phone: Mobile Phone: ---------- Preferred Phone: Home or Mobile (circle one) Email: -----------

More information

Come prepared: What you can expect:

Come prepared: What you can expect: Welcome! Thank you for choosing the Headache Clinic at University of Colorado Hospital for your health care needs. Targeting the best outcomes for patients, our providers bring together top expertise and

More information

Chantal O Brien, MD Jeff Reynek, NP Jessica Scharein, DNP

Chantal O Brien, MD Jeff Reynek, NP Jessica Scharein, DNP Welcome! Thank you for choosing the Headache Clinic at University of Colorado Hospital for your health care needs. Targeting the best outcomes for patients, our providers bring together top expertise and

More information

Current Complaint Please briefly describe the reason for your visit to our office today:

Current Complaint Please briefly describe the reason for your visit to our office today: MEDICAL HISTORY Please complete the following information: Patient name: D.O.B. Date: *The following information is very important to us in taking care of your health. Please take the time to fill out

More information

Have You Ever Wondered

Have You Ever Wondered Have You Ever Wondered A few facts about medication use and related falls The Number of Medications You Take & The Connection to Falls CONCERN: As you increase the number of medications that you take,

More information

Thank you, again, for allowing us to participate in your health care. We look forward to working with you!

Thank you, again, for allowing us to participate in your health care. We look forward to working with you! Welcome! Thank you for choosing the Headache Clinic at University of Colorado Hospital for your health care needs. To obtain the best outcomes for patients, the providers at the UCHealth Headache Clinic

More information

Headache Intake Assessment Form

Headache Intake Assessment Form Headache Intake Assessment Form Name: Date: Age: Sex: M F Marital Status Name of Spouse: Name(s) and Age(s) of children: Names & Types of Pets: Education: Occupation: Spouse s occupation: Does anyone in

More information

APPENDIX E: HEALTHCARE PRACTITIONER- REPORTED REDUCTION OF PAIN MEDICATION

APPENDIX E: HEALTHCARE PRACTITIONER- REPORTED REDUCTION OF PAIN MEDICATION Contents Appendix E: Healthcare Practitioner-Reported Reduction of Pain Medication... E-1 Appendix E: Healthcare Practitioner- Reported Reduction of Pain Medication Note: Word choice and spellings have

More information

PAIN. TREATMENT TABLES Analgesics. NON-OPIOID ANALGESICS Generic Name Trade Names (Examples) Duration Initial Dose

PAIN. TREATMENT TABLES Analgesics. NON-OPIOID ANALGESICS Generic Name Trade Names (Examples) Duration Initial Dose NON-OPIOID SHORT-ACTING LONG-ACTING **** O PAIN TREATMENT TABLES Analgesics NON-OPIOID ANALGESICS Generic Name Trade Names (Examples) Duration Initial Dose Tramadol 50 mg Ultram Every 4 hours 1-2 tabs,

More information

Department of Neurology Headache Questionnaire

Department of Neurology Headache Questionnaire Department of Neurology Headache Questionnaire first Name: last Name: Date of birth: primary care provider & clinic: previous neurologist: At what age did you have your first headache: What year did your

More information

MEDICATION HISTORY FORM

MEDICATION HISTORY FORM MEDICATION HISTORY FORM Please highlight or circle medications you have tried. Please indicate if they worked (W), didn t work (DW) or if there were any side effects (SE). Over the Counter Aspirin Aleve

More information

INITIAL COMPREHENSIVE PAIN QUESTIONNAIRE

INITIAL COMPREHENSIVE PAIN QUESTIONNAIRE INITIAL COMPREHENSIVE PAIN QUESTIONNAIRE Name: DOB: Address: Phone number: Referring Physician name: PAIN HISTORY: Was the pain a result of a particular incident (injury, accident, illness): No Yes (please

More information

Headache Questionnaire

Headache Questionnaire Date: All Headache Patients We would appreciate your cooperation in filling out this form. In our evaluation of headache, your history is typically our most valuable tool for diagnosis and subsequent treatment.

More information

Medications and Children Disorders

Medications and Children Disorders Mental Health Comprehensive Services Providing Family Stability and Developing Life Coping Skills Medications and Children Disorders Psychiatric medications can be an effective part of the treatment for

More information

Short Clinical Guidelines: Headache, Key Points for Diagnosis and Treatment

Short Clinical Guidelines: Headache, Key Points for Diagnosis and Treatment Clinical Highlights 1. Headache is diagnosed by history and physical examination with limited need for imaging or laboratory tests. 2. Warning signs of possible disorder other than primary headache are:

More information

Drug Name (select from list of drugs shown / provide drug information) Patient Information. Prescribing Physician

Drug Name (select from list of drugs shown / provide drug information) Patient Information. Prescribing Physician Texas Standard Prior Authorization Form Addendum MOLINA TX MARKETPLACE Botulinum Toxins CL Molina Universal This fax machine is located in a secure location as required by HIPAA Regulations. Complete /

More information

NEW PATIENT QUESTIONNAIRE

NEW PATIENT QUESTIONNAIRE NEW PATIENT QUESTIONNAIRE PATIENT NAME: PRIMARY DOCTOR: DATE: REFERRING DOCTOR: Please show the location of your pain by drawing on the figures below: Pain History 1. WHERE IS YOUR PAIN LOCATED? 0 Low

More information

HYSINGLA ER (hydrocodone bitartrate) Prior authorization is not required if prescribed by an oncologist.

HYSINGLA ER (hydrocodone bitartrate) Prior authorization is not required if prescribed by an oncologist. Pre - PA Allowance None Prior authorization is not required if prescribed by an oncologist. Prior-Approval Requirements Age 18 years of age or older Diagnosis Patient must have the following: 1. Pain,

More information

General Patient Information Dr. David A. Branch, M.D.

General Patient Information Dr. David A. Branch, M.D. General Patient Information Dr. David A. Branch, M.D. **Please Print** Patient Name: Date of Birth: Social Security # Email Address: Patient Address: _ City: State: Zip Code: Phone : Marital Status: S

More information

Understanding Migraines

Understanding Migraines Understanding Migraines Migraine is a severe headache syndrome that recurs. Migraine headaches are usually throbbing, but may also be described as exploding, shooting, or squeezing. Migraine headaches

More information

SOME PEOPLE HAVE MORE THAN ONE TYPE OF HEADACHE -

SOME PEOPLE HAVE MORE THAN ONE TYPE OF HEADACHE - Dr. Brenda C. Slovin Dr. Erik S. Slovin 203-840-0000 203-840-0011 (Fax) Pain relief without drugs or surgery! www.eliminatemigrainepain.com www.slovinchiropractic.com www.beatingpainandfatigue.com www.endmigrainesnow.com

More information

Pre - PA Allowance. Prior-Approval Requirements LEVORPHANOL TARTRATE. None

Pre - PA Allowance. Prior-Approval Requirements LEVORPHANOL TARTRATE. None Pre - PA Allowance None Prior-Approval Requirements Prior authorization is not required if prescribed by an oncologist and/or the member has paid pharmacy claims for an oncology medication(s) in the past

More information

Head Pain Intake Form

Head Pain Intake Form Head Pain Intake Form NEUROLOGY LLC Your evaluation will take one hour to complete and in order to best utilize the time, please take the time to complete this questionnaire prior to your appointment.

More information

MORPHINE IR DRUG CLASS Morphine IR, Dilaudid IR (hydromorphone), Opana IR (oxymorphone)

MORPHINE IR DRUG CLASS Morphine IR, Dilaudid IR (hydromorphone), Opana IR (oxymorphone) Pre - PA Allowance Tablets & Suppositories Morphine sulfate tablets Morphine sulfate suppositories Oxymorphone tablets Hydromorphone tablets Hydromorphone suppositories 360 tablets per 90 days OR 360 suppositories

More information

Levorphanol. Levorphanol Tartrate. Description

Levorphanol. Levorphanol Tartrate. Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.59 Subject: Levorphanol Page: 1 of 8 Last Review Date: March 16, 2018 Levorphanol Description Levorphanol

More information

Initial Pain Questionnaire

Initial Pain Questionnaire Initial Pain Questionnaire Date: Name: Address: Last First Middle Initial Street Address City State Zip Home Phone Cell : Work: Referring Physician: Other Physicians: Age: PAIN HISTORY: What is the main

More information

Chief, Pediatric Neurology PEDIATRIC HEADACHE QUESTIONNAIRE

Chief, Pediatric Neurology PEDIATRIC HEADACHE QUESTIONNAIRE Pediatric Neurology Weill Cornell Medical Center New York Presbyterian Hospital 505 E 70 th Street 3 rd Floor New York, NY 10021 Phone: 212-746-3278 Fax: 212-746-8137 Barry E. Kosofsky, MD, PhD Chief,

More information

Duragesic Patch (fentanyl patch) Prior authorization is not required if prescribed by an oncologist

Duragesic Patch (fentanyl patch) Prior authorization is not required if prescribed by an oncologist Pre - PA Allowance Quantity 30 patches every 90 days Prior-Approval Requirements Prior authorization is not required if prescribed by an oncologist Age 2 years of age or older Diagnosis Patient must have

More information

Nucynta IR. Nucynta IR (tapentadol immediate-release) Description

Nucynta IR. Nucynta IR (tapentadol immediate-release) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Nucynta IR Page: 1 of 9 Last Review Date: December 8, 2017 Nucynta IR Description Nucynta IR (tapentadol

More information

Happy Daisy Ltd. New Client intake Form. What are the issues for which you are seeking care?

Happy Daisy Ltd. New Client intake Form. What are the issues for which you are seeking care? Happy Daisy Ltd. New Client intake Form Name Date Preferred name Pronouns Referred by Date of birth Age Race What are the issues for which you are seeking care? 1. 2. 3. Please check of any of the symptoms

More information

Hysingla ER. Hysingla ER (hydrocodone bitartrate) Description

Hysingla ER. Hysingla ER (hydrocodone bitartrate) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.38 Subject: Hysingla ER Page: 1 of 9 Last Review Date: September 15, 2017 Hysingla ER Description

More information

TRANSCRANIAL MAGNETIC STIMULATION & BRAIN MUSIC THERAPY

TRANSCRANIAL MAGNETIC STIMULATION & BRAIN MUSIC THERAPY TMS - DEPRESSION HISTORY Date: Patient Name: DOB: How did you hear about TMS? What do you know about TMS? Referring Physician? Name of Practice: Name of Inpatient Treatment for Depression: Name of Inpatient

More information

Butrans (buprenorphine patch) Description. Section: Prescription Drugs Effective Date: October 1, 2017

Butrans (buprenorphine patch) Description. Section: Prescription Drugs Effective Date: October 1, 2017 Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Butrans Page: 1 of 9 Last Review Date: September 15, 2017 Butrans (buprenorphine patch) Description

More information

Embeda. Embeda (morphine sulfate and naltrexone hydrochloride) Description

Embeda. Embeda (morphine sulfate and naltrexone hydrochloride) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.39 Subject: Embeda Page: 1 of 8 Last Review Date: September 15, 2017 Embeda Description Embeda (morphine

More information

PAIN SOLUTIONS NEW PATIENT QUESTIONNAIRE

PAIN SOLUTIONS NEW PATIENT QUESTIONNAIRE PAIN SOLUTIONS NEW PATIENT QUESTIONNAIRE Patient Name: DATE Primary Doctor: Referring Doctor: Please show the location of your pain by drawing on the figures below: Pain History (PLEASE FILL IN THE BUBBLES)

More information

Belbuca (buprenorphine buccal film) Belbuca (buprenorphine buccal film) Description

Belbuca (buprenorphine buccal film) Belbuca (buprenorphine buccal film) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Belbuca Page: 1 of 9 Last Review Date: September 15, 2017 Belbuca (buprenorphine buccal film)

More information

Study Guidelines for Quiz #1

Study Guidelines for Quiz #1 Annex to Section J Page 1 Study Guidelines for Quiz #1 Theory and Principles of Psychopharmacology, Classifications and Neurotransmitters, Anxiolytics/Antianxiety/Minor Tranquilizers, Stimulants, Nursing

More information

PSYCHIATRY INTAKE FORM

PSYCHIATRY INTAKE FORM Please complete all information on this form. PSYCHIATRY INTAKE FORM Name Date Date of Birth Primary Care Physician Current Therapist/Counselor What are the problem(s) for which you are seeking help? 1.

More information

Goals. Primary Headache Syndromes. One-Year Prevalence of Common Headache Disorders

Goals. Primary Headache Syndromes. One-Year Prevalence of Common Headache Disorders Goals One-Year Prevalence of Common Headache Disorders Impact of primary headache syndromes Non pharmacologic Rx of migraine individualized to patient triggers Complementary and alternative Rx of migraine

More information

Duragesic patch. Duragesic patch (fentanyl patch) Description. Section: Prescription Drugs Effective Date: January 1, 2019

Duragesic patch. Duragesic patch (fentanyl patch) Description. Section: Prescription Drugs Effective Date: January 1, 2019 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Duragesic patch Page: 1 of 9 Last Review Date: November 30, 2018 Duragesic patch Description Duragesic patch (fentanyl

More information

Morphine IR Hydromorphone IR Oxymorphone IR. Morphine IR, Dilaudid IR (hydromorphone), Opana IR (oxymorphone),

Morphine IR Hydromorphone IR Oxymorphone IR. Morphine IR, Dilaudid IR (hydromorphone), Opana IR (oxymorphone), Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.33 Subject: Morphine IR Drug Class Page: 1 of 11 Last Review Date: December 8, 2017 Morphine IR Hydromorphone

More information

Strategies in Migraine Care

Strategies in Migraine Care Strategies in Migraine Care Julie L. Roth, MD Rhode Island Hospital Assistant Professor, Neurology The Warren Alpert Medical School of Brown University March 28, 2015 Financial Disclosures None. Objectives

More information

Demerol (meperidine oral tablet, oral solution), Meperitab (oral tablet)

Demerol (meperidine oral tablet, oral solution), Meperitab (oral tablet) Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Meperidine Page: 1 of 7 Last Review Date: September 15, 2017 Meperidine Description Demerol (meperidine

More information

Appendix: Psychotropic Medication Reference Tables

Appendix: Psychotropic Medication Reference Tables Appendix: Psychotropic Medication Reference Tables How to Use these Tables These reference tables are designed to provide clinic staff with specific medication related criteria for the Polypharmacy, Cardiometabolic

More information

PATIENT REGISTRATION

PATIENT REGISTRATION Account# PATIENT REGISTRATION Please answer all questions completely. PAYMENT IS EXPECTED WHEN SERVICES ARE RENDERED Date New Update Name Date of Birth Male Last First Middle Female Home Address City/State/Zip

More information

Levorphanol. Levorphanol Tartrate. Description

Levorphanol. Levorphanol Tartrate. Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.59 Subject: Levorphanol Page: 1 of 8 Last Review Date: March 17, 2017 Levorphanol Description Levorphanol

More information

You have an appointment with Dr. Santiago Mazuera am

You have an appointment with Dr. Santiago Mazuera am NEUROLOGY DEPARTMENT AT NORTHWEST Northwest Hospital Professional Center 5415 Old Court Road, Street Level, Suite S04 Randallstown MD 21133 Phone: 410-601-9515 // Fax: 410-601-8905 Welcome! This packet

More information

JEFFERSON HEADACHE CENTER

JEFFERSON HEADACHE CENTER JEFFERSON HEADACHE CENTER Patient History Name: D.OB: Age: M F Address: Birthplace: Phone: (H) (W) (C) Marital Status: S M W DIV SEP Religion: Race: Referred by: primary care physician other neurologist

More information

Please provide your referring or regular doctor s full name, address, phone number, and fax number. HEADACHE HISTORY

Please provide your referring or regular doctor s full name, address, phone number, and fax number. HEADACHE HISTORY PATIENT INFORMATION Patient Name (Last, First, Maiden) Date of Birth Age Social Security Number Please provide your referring or regular doctor s full name, address, phone number, and fax number. Referring

More information

1. On how many days in the last 3 months did you miss work or school because of your headaches?

1. On how many days in the last 3 months did you miss work or school because of your headaches? The Migraine Disability Assessment Test The MIDAS (Migraine Disability Assessment) questionnaire was put together to help you measure the impact your headaches have on your life. The information on this

More information

Legacy Pain Management Center New Patient Questionnaire

Legacy Pain Management Center New Patient Questionnaire Legacy Pain Management Center New Patient Questionnaire Please complete this form prior to your visit to allow us to make the best use of our time together. Primary Care Provider: Referring Physician:

More information

Belbuca (buprenorphine buccal film) Description. Section: Prescription Drugs Effective Date: October 1, 2016

Belbuca (buprenorphine buccal film) Description. Section: Prescription Drugs Effective Date: October 1, 2016 Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Belbuca Page: 1 of 9 Last Review Date: September 15, 2016 Belbuca (buprenorphine buccal film)

More information

PATIENT REGISTRATION

PATIENT REGISTRATION Account# PATIENT REGISTRATION Please answer all questions completely. PAYMENT IS EXPECTED WHEN SERVICES ARE RENDERED Date New Update Name Date of Birth Male Last First Middle Female Home Address City/State/Zip

More information

PAIN. (Review article for physicians) Method of Alexander Mauskop, MD New York Headache Center, New York, NY. From Connâs Current Therapy, 1996

PAIN. (Review article for physicians) Method of Alexander Mauskop, MD New York Headache Center, New York, NY. From Connâs Current Therapy, 1996 PAIN (Review article for physicians) Method of Alexander Mauskop, MD New York Headache Center, New York, NY. From Connâs Current Therapy, 1996 PHARMACOTHERAPY Major advances are being made in the development

More information

90 dosage units per 90 days OR. Extended-release Formulations Ultram ER 90 dosage units per 90 days OR

90 dosage units per 90 days OR. Extended-release Formulations Ultram ER 90 dosage units per 90 days OR Pre - PA Allowance 12 years of age or older Quantity Immediate-release Formulation Ultracet 720 dosage units per 90 days OR Ultram 720 dosage units per 90 days Extended-release Formulations Ultram ER 90

More information

Duragesic patch. Duragesic patch (fentanyl patch) Description

Duragesic patch. Duragesic patch (fentanyl patch) Description 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.31 Subject: Duragesic patch Page: 1 of 9 Last Review Date: September 15, 2017 Duragesic patch Description Duragesic patch (fentanyl

More information

Headache Questionnaire

Headache Questionnaire This headache questionnaire is crucial to help us understand you and give you the best care. By completing it, you maximize your time with us at Center for Healing Neurology. This lets us focus on providing

More information

NEW PATIENT INFORMATION SHEET

NEW PATIENT INFORMATION SHEET Akintomi A. Olugbodi M.D. 301 S. Seventh Ave. Suite 315 West Reading, PA 19611 (484) 869-2817 NEW PATIENT INFORMATION SHEET PLEASE COMPLETE THESE FORMS PRIOR TO YOUR APPOINTMENT AND BRING THEM WITH YOU

More information

Duragesic patch. Duragesic patch (fentanyl patch) Description

Duragesic patch. Duragesic patch (fentanyl patch) Description 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.31 Section: Prescription Drugs Effective Date: April1, 2017 Subject: Duragesic patch Page: 1 of 10 Last Review Date: March

More information

Commonly Used Medicines (Both Prescription and Over-the-Counter) That Interact With Alcohol

Commonly Used Medicines (Both Prescription and Over-the-Counter) That Interact With Alcohol Commonly Used Medicines (Both Prescription and Over-the-Counter) That Interact With Alcohol Symptom/Disorders Medication (Brand name) Medication (Generic name) Some possible reactions with alcohol Allergies/Colds/Flu

More information

Guide to Psychiatric Medications for Children and Adolescents

Guide to Psychiatric Medications for Children and Adolescents Guide to Psychiatric Medications for Children and Adolescents by Glenn S. Hirsch, M.D. The following guide includes most of the medications used to treat child and adolescent mental disorders. It lists

More information

B) If any item or statement on this form applies to you, please check the square corresponding to that item or statement.

B) If any item or statement on this form applies to you, please check the square corresponding to that item or statement. PATIENT INSTRUCTIONS FOR COMPLETING THE : A) This detailed questionnaire of your health history is extremely important. Your past health experiences play a major role in developing a successful treatment

More information

Targiniq ER (oxycodone/naloxone extended-release), Troxyca ER (oxycodone /naltrexone extended-release)

Targiniq ER (oxycodone/naloxone extended-release), Troxyca ER (oxycodone /naltrexone extended-release) Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.44 Subject: Oxycodone Naloxone Page: 1 of 9 Last Review Date: December 2, 2016 Oxycodone Naloxone

More information

ABINGTON NEUROLOGICAL ASSOCIATES (215)

ABINGTON NEUROLOGICAL ASSOCIATES (215) ABINGTON NEUROLOGICAL ASSOCIATES (215) 957-9250 Name Birth date Age: (Month/Day/Year) Address Birthplace Zip code Phone (Home) (Work) (Cell) (Other) Marital Status:! M! S! W! D Religion Race Handedness:!

More information

Oxycodone. Oxycodone IR, Oxycodone ER, OxyContin, Xtampza ER. Description

Oxycodone. Oxycodone IR, Oxycodone ER, OxyContin, Xtampza ER. Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Oxycodone Page: 1 of 11 Last Review Date: March 17, 2017 Oxycodone Description Oxycodone IR, Oxycodone

More information

Oxycodone. Oxycodone IR, Oxycodone ER, OxyContin, Xtampza ER. Description

Oxycodone. Oxycodone IR, Oxycodone ER, OxyContin, Xtampza ER. Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Oxycodone Page: 1 of 10 Last Review Date: September 15, 2016 Oxycodone Description Oxycodone IR,

More information

used for dealing with anxiety. Both of the drugs are also given to patients for dealing with pain activated by damaged or hypersensitive nerves that i

used for dealing with anxiety. Both of the drugs are also given to patients for dealing with pain activated by damaged or hypersensitive nerves that i Aspirin (also classified under NSAIDs or acetylsalicylic acid). Morphine and morphine sustained release (MS-Contin, Avinza, Kadian) Oxymorphone (Opana, Opana ER) Hydrocodone with acetaminophen (Lortab

More information

Psychotropic Medications Archana Jhawar, PharmD, BCPP Clinical Faculty of UIC Pharmacy Practice Clinical Psychiatric Pharmacist Jesse Brown VA

Psychotropic Medications Archana Jhawar, PharmD, BCPP Clinical Faculty of UIC Pharmacy Practice Clinical Psychiatric Pharmacist Jesse Brown VA Psychotropic Medications Archana Jhawar, PharmD, BCPP Clinical Faculty of UIC Pharmacy Practice Clinical Psychiatric Pharmacist Jesse Brown VA Goals of Medications Use least number at lowest dose to get

More information

Triptan Quantity Limit

Triptan Quantity Limit *- Florida Healthy Kids Triptan Quantity Limit Override(s) Quantity Limit Approval Duration 1 year Oral Tablets Axert (almotriptan) tablets Relpax (eletriptan) tablets 6 tablets (6.25 mg) 12 tablets (12.5

More information

AAA. add dan campbell artwork cats? Report #12 Changes in Medication Use over Time in Adolescents and Adults with Autism Spectrum Disorders

AAA. add dan campbell artwork cats? Report #12 Changes in Medication Use over Time in Adolescents and Adults with Autism Spectrum Disorders AAA Adolescents & Adults with Autism A Study of Family Caregiving add dan campbell artwork cats? Report #12 Changes in Medication Use over Time in Adolescents and Adults with Autism Spectrum Disorders

More information

NorthSTAR. Pharmacy Manual

NorthSTAR. Pharmacy Manual NorthSTAR Pharmacy Manual Revised October, 2008 Table of I. Introduction II. III. IV. Antidepressants New Generation Antipsychotic Medications Mood Stabilizers V. ADHD Medications VI. Anxiolytics and Sedative-Hypnotics

More information

OH, MY ACHING HEAD! I HAVE NO DISCLOSURES OR CONFLICTS OF INTERESTS TO DECLARE MANAGING HEADACHE IN THE OUTPATIENT SETTING SECONDARY HEADACHES

OH, MY ACHING HEAD! I HAVE NO DISCLOSURES OR CONFLICTS OF INTERESTS TO DECLARE MANAGING HEADACHE IN THE OUTPATIENT SETTING SECONDARY HEADACHES 1 JUSTIN A. OSSMAN, MD CHATTANOOGA FAMILY MEDICINE UPDATE OH, MY ACHING HEAD! MANAGING HEADACHE IN THE OUTPATIENT SETTING 2 I HAVE NO DISCLOSURES OR CONFLICTS OF INTERESTS TO DECLARE OBJECTIVES International

More information

Index. Prim Care Clin Office Pract 31 (2004) Note: Page numbers of article titles are in boldface type.

Index. Prim Care Clin Office Pract 31 (2004) Note: Page numbers of article titles are in boldface type. Prim Care Clin Office Pract 31 (2004) 441 447 Index Note: Page numbers of article titles are in boldface type. A Abscess, brain, headache in, 388 Acetaminophen for migraine, 406 407 headache from, 369

More information

Richard Heidenfelder M.D. Child, Adolescent and Adult Psychiatry 447 9th Ave San Diego, CA

Richard Heidenfelder M.D. Child, Adolescent and Adult Psychiatry 447 9th Ave San Diego, CA *We are not accepting any New Patients who are currently taking any controlled pain medications *We are *Note: not completion accepting of the any following New Patients paperwork who and Initial are Screening

More information

Review of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course)

Review of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course) Review of Psychotrophic Medications (An approved North Carolina Division of Health Services Regulation Continuing Education Course) Common Psychiatric Disorders *Schizophrenia *Depression *Bipolar Disorder

More information

Mental Health Intake Form

Mental Health Intake Form Current Symptoms Checklist: (check once for any symptoms present, twice for major symptoms) ( ) ( ) Depressed mood ( ) ( ) Racing thoughts ( ) ( ) Excessive worry ( ) ( ) Unable to enjoy activities ( )

More information

NEW PATIENTS' INFORMATION SHEET

NEW PATIENTS' INFORMATION SHEET NEW PATIENTS' INFORMATION SHEET Please print clearly. Please complete all information so that your claim can be processed quickly and efficiently. Thank you! PATIENT INFORMATION (First) (MI) (Last) Name

More information

INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE, MARYLAND QUARTERLY REPORT: FOURTH QUARTER, 2008 AND 2008 SUMMARY

INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE, MARYLAND QUARTERLY REPORT: FOURTH QUARTER, 2008 AND 2008 SUMMARY INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE, MARYLAND QUARTERLY REPORT: FOURTH QUARTER, 2008 AND 2008 SUMMARY A report from the Office of Epidemiology and Planning Baltimore

More information

Dealing with a Mental Health Crisis

Dealing with a Mental Health Crisis Dealing with a Mental Health Crisis Information and Resources for First Responders P... PROFESSIONAL WHAT NAMI DOES NAMI Minnesota is a statewide 501(c)(3) grassroots nonprofit organization dedicated to

More information

USF Health Psychiatry Clinic. New Patient Questionnaire Adult

USF Health Psychiatry Clinic. New Patient Questionnaire Adult USF Health Psychiatry Clinic New Patient Questionnaire Adult Please mail or fax the completed forms to the address/fax number on the bottom of this page. Completed forms must be received five (5) days

More information

Methadone. Description

Methadone. Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.41 Subject: Methadone Page: 1 of 11 Last Review Date: September 15, 2017 Methadone Description Dolophine

More information

INITIAL PAIN QUESTIONNAIRE

INITIAL PAIN QUESTIONNAIRE INITIAL PAIN QUESTIONNAIRE 501 Cetronia Road, Suite 125 Allentown, PA 18104 830 Ostrum Street Bethlehem, PA 18015 3 Parkinsons Road East Stroudsburg, PA 18301 1700 St. Luke s Boulevard, Suite 200 Easton,

More information

Morphine Sulfate Hydromorphone Oxymorphone

Morphine Sulfate Hydromorphone Oxymorphone Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.33 Subject: Morphine Drug Class Page: 1 of 12 Last Review Date: September 15, 2017 Morphine Sulfate

More information

OXYCODONE IR (oxycodone)

OXYCODONE IR (oxycodone) RATIONALE FOR INCLUSION IN PA PROGRAM Background Oxycodone hydrochloride, a pure opioid agonist, is used in the treatment of moderate to severe pain (1-2). The precise mechanism of action is unknown; however,

More information

May 22, DAL: DAL SUBJECT: Hot Weather Advisory. Dear Administrator/Operator:

May 22, DAL: DAL SUBJECT: Hot Weather Advisory. Dear Administrator/Operator: May 22, 2013 DAL: DAL 13-11 SUBJECT: Hot Weather Advisory Dear Administrator/Operator: The New York State Department of Health would like to remind you of our expectations regarding the protection of Adult

More information

Steps for Initiating Electroconvulsive Therapy Treatment

Steps for Initiating Electroconvulsive Therapy Treatment Steps for Initiating Electroconvulsive Therapy Treatment PSYCHIATRISTS CAN REFER PATIENTS FOR ECT TREATMENT AT EL CAMINO HOSPITAL BY CALLING THE ECT NURSE COORDINATOR AT 650-962-5795. Once the referral

More information

Methadone. Description

Methadone. Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.41 Subject: Methadone Page: 1 of 13 Last Review Date: March 16, 2018 Methadone Description Dolophine

More information

BELBUCA (buprenorphine buccal film)

BELBUCA (buprenorphine buccal film) RATIONALE FOR INCLUSION IN PA PROGRAM Background Belbuca is indicated for the management of chronic pain severe enough to require daily, aroundthe-clock, long-acting opioid treatment for which alternative

More information

ChemaTox Blood Drug Testing Matrix (Updated May 24th, 2016)

ChemaTox Blood Drug Testing Matrix (Updated May 24th, 2016) ChemaTox Blood Drug Testing Matrix (Updated May 24th, 2016) Email: DREtox@chematox.com; Phone: (303)440-4500 Always identify any medications/drugs the suspect states they have taken, or that you suspect

More information

NEW PATIENT INFORMATION FORM

NEW PATIENT INFORMATION FORM 1031 WEST WILLIAMS STREET, SUITE 102, APEX, NC 27502 PHONE (919) 439-7867 FAX (919) 573-9594 NEW PATIENT INFORMATION FORM All patients (new and returning) are subject to the following no-show/broken appointment

More information

RATIONALE FOR INCLUSION IN PA PROGRAM

RATIONALE FOR INCLUSION IN PA PROGRAM RATIONALE FOR INCLUSION IN PA PROGRAM Background Tramadol is a centrally acting synthetic opioid analgesic used to treat moderate to moderately severe chronic pain in adults. Along from analgesia, tramadol

More information

EPWORTH SLEEPINESS SCALE

EPWORTH SLEEPINESS SCALE EPWORTH SLEEPINESS SCALE Name: Sponsors last 4 of SSN#: DOB: Today s Date: Age (years): Gender (circle): MALE FEMALE How likely are you to doze off or fall asleep in the following situation, in contrast

More information

Treatment of Primary Headache Syndromes

Treatment of Primary Headache Syndromes Presenter Disclosure Information 2:45 3:45pm Treatment of Primary Headache Syndromes SPEAKER Gerald W. Smetana, MD The following relationships exist related to this presentation: Gerald W.Smetana, MD,

More information

INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE CITY

INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE CITY 2009 FINAL REPORT INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE CITY This report was prepared by: Dr. Jose Arbelaez, M.D. of Baltimore Substance Abuse Systems, and Ryan J. Petteway,

More information

Approach to a Patient with Headache

Approach to a Patient with Headache Approach to a Patient with Headache J.D. Bartleson, MD Professor of Neurology Mayo Clinic College of Medicine 15 th Annual Internal Medicine Conference March 25, 2018 Boca Raton, FL 2014 MFMER slide-1

More information

Xartemis XR (oxycodone / acetaminophen extended release)

Xartemis XR (oxycodone / acetaminophen extended release) RATIONALE FOR INCLUSION IN PA PROGRAM Background Xartemis XR is a combination of oxycodone and acetaminophen in a dosage formulation to deliver both immediate pain relief, in less than an hour, and extended-release

More information

ADVANCES IN MIGRAINE MANAGEMENT

ADVANCES IN MIGRAINE MANAGEMENT ADVANCES IN MIGRAINE MANAGEMENT Joanna Girard Katzman, M.D.MSPH Assistant Professor, Dept. of Neurology Project ECHO, Chronic Pain Program University of New Mexico Outline Migraine throughout the decades

More information

Understanding Migraines and Treatment Options. Simplified Diagnosis of Migraine. Migraine Prevalence American Migraine Study II

Understanding Migraines and Treatment Options. Simplified Diagnosis of Migraine. Migraine Prevalence American Migraine Study II Understanding Migraines and Treatment Options Deborah C. Zajac, RN-BC Center for Headache and Pain Neurological Institute Cleveland Clinic Simplified Diagnosis of Migraine Any person with a stable pattern

More information